Press Releases Bioventus Inc.

Equities

BVS

US09075A1088

Real-time Estimate Cboe BZX Other stock markets 11:48:19 2024-05-08 am EDT			5-day change	1st Jan Change
4.995 ^USD	-2.44%		+25.81%	-4.74%

May. 07	Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024	CI
May. 07	Bioventus Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bioventus : Q1'24 Earnings Call Slides	May. 07	PU
Bioventus Reports First Quarter Financial Results	May. 07	AQ
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024	Apr. 29	AQ
Bioventus : Q4’23 Earnings Call Slides	Mar. 12	PU
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 12	AQ
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024	Mar. 04	AQ
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	Jan. 18	AQ
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole	Jan. 12	AQ
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	Dec. 26	BU
Bioventus Names Robert Claypoole as President and Chief Executive Officer	Dec. 19	AQ
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis	Dec. 06	AQ
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance	Nov. 07	AQ
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023	23-10-31	AQ
Bioventus to Present at the Cantor Global Healthcare Conference	23-09-19	AQ
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference	23-09-06	AQ
Bioventus : Q2’23 Earnings Call Slides	23-08-08	PU
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance	23-08-08	AQ
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference	23-08-04	AQ
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023	23-08-01	AQ
BIOVENTUS INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-06-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bioventus Inc.

Equities

BVS

US09075A1088

Press Releases

Filters